Literature DB >> 24214409

Developing an international Pseudomonas aeruginosa reference panel.

Anthony De Soyza1, Amanda J Hall, Eshwar Mahenthiralingam, Pavel Drevinek, Wieslaw Kaca, Zuzanna Drulis-Kawa, Stoyanka R Stoitsova, Veronika Toth, Tom Coenye, James E A Zlosnik, Jane L Burns, Isabel Sá-Correia, Daniel De Vos, Jean-Paul Pirnay, Timothy J Kidd, David Reid, Jim Manos, Jens Klockgether, Lutz Wiehlmann, Burkhard Tümmler, Siobhán McClean, Craig Winstanley.   

Abstract

Pseudomonas aeruginosa is a major opportunistic pathogen in cystic fibrosis (CF) patients and causes a wide range of infections among other susceptible populations. Its inherent resistance to many antimicrobials also makes it difficult to treat infections with this pathogen. Recent evidence has highlighted the diversity of this species, yet despite this, the majority of studies on virulence and pathogenesis focus on a small number of strains. There is a pressing need for a P. aeruginosa reference panel to harmonize and coordinate the collective efforts of the P. aeruginosa research community. We have collated a panel of 43 P. aeruginosa strains that reflects the organism's diversity. In addition to the commonly studied clones, this panel includes transmissible strains, sequential CF isolates, strains with specific virulence characteristics, and strains that represent serotype, genotype or geographic diversity. This focussed panel of P. aeruginosa isolates will help accelerate and consolidate the discovery of virulence determinants, improve our understanding of the pathogenesis of infections caused by this pathogen, and provide the community with a valuable resource for the testing of novel therapeutic agents.
© 2013 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cystic fibrosis; Pseudomonas aeruginosa; genotype; pathogen

Mesh:

Year:  2013        PMID: 24214409      PMCID: PMC3892346          DOI: 10.1002/mbo3.141

Source DB:  PubMed          Journal:  Microbiologyopen        ISSN: 2045-8827            Impact factor:   3.139


  91 in total

1.  Identification of a genomic island present in the majority of pathogenic isolates of Pseudomonas aeruginosa.

Authors:  X Liang; X Q Pham; M V Olson; S Lory
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

2.  Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis.

Authors:  Nadine Hoffmann; Thomas Bovbjerg Rasmussen; Peter Østrup Jensen; Charlotte Stub; Morten Hentzer; Søren Molin; Oana Ciofu; Michael Givskov; Helle Krogh Johansen; Niels Høiby
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis.

Authors:  Paul C Blainey; Carlos E Milla; David N Cornfield; Stephen R Quake
Journal:  Sci Transl Med       Date:  2012-09-26       Impact factor: 17.956

4.  Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.

Authors:  Eilidh Mowat; Steve Paterson; Joanne L Fothergill; Elli A Wright; Martin J Ledson; Martin J Walshaw; Michael A Brockhurst; Craig Winstanley
Journal:  Am J Respir Crit Care Med       Date:  2011-02-04       Impact factor: 21.405

5.  Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.

Authors:  Richard Bradbury; Alan Champion; David W Reid
Journal:  Respirology       Date:  2008-11       Impact factor: 6.424

6.  Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

Authors:  K Cheng; R L Smyth; J R Govan; C Doherty; C Winstanley; N Denning; D P Heaf; H van Saene; C A Hart
Journal:  Lancet       Date:  1996-09-07       Impact factor: 79.321

7.  Flagellin glycosylation in Pseudomonas aeruginosa PAK requires the O-antigen biosynthesis enzyme WbpO.

Authors:  Wayne L Miller; Mauricia J Matewish; David J McNally; Noboru Ishiyama; Erin M Anderson; Dyanne Brewer; Jean-Robert Brisson; Albert M Berghuis; Joseph S Lam
Journal:  J Biol Chem       Date:  2007-12-07       Impact factor: 5.157

8.  Intraclonal genetic diversity amongst cystic fibrosis and keratitis isolates of Pseudomonas aeruginosa.

Authors:  Amanda J Hall; Joanne L Fothergill; Stephen B Kaye; Timothy J Neal; Paul S McNamara; Kevin W Southern; Craig Winstanley
Journal:  J Med Microbiol       Date:  2012-10-25       Impact factor: 2.472

9.  Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung.

Authors:  Jim Manos; Jonathan Arthur; Barbara Rose; Pholawat Tingpej; Carina Fung; Michelle Curtis; Jeremy S Webb; Honghua Hu; Staffan Kjelleberg; Mark D Gorrell; Peter Bye; Colin Harbour
Journal:  J Med Microbiol       Date:  2008-12       Impact factor: 2.472

10.  Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes.

Authors:  Geoffrey L Winsor; David K W Lam; Leanne Fleming; Raymond Lo; Matthew D Whiteside; Nancy Y Yu; Robert E W Hancock; Fiona S L Brinkman
Journal:  Nucleic Acids Res       Date:  2010-10-06       Impact factor: 16.971

View more
  34 in total

1.  A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.

Authors:  Manon F Pritchard; Lydia C Powell; Alison A Jack; Kate Powell; Konrad Beck; Hannah Florance; Julian Forton; Philip D Rye; Arne Dessen; Katja E Hill; David W Thomas
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.

Authors:  Sarah Tavernier; Aurélie Crabbé; Mayram Hacioglu; Liesbeth Stuer; Silke Henry; Petra Rigole; Inne Dhondt; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Pseudomonas aeruginosa mexT is an indicator of PAO1 strain integrity.

Authors:  Eric D LoVullo; Herbert P Schweizer
Journal:  J Med Microbiol       Date:  2019-12-18       Impact factor: 2.472

4.  Alginate Oligosaccharide-Induced Modification of the lasI-lasR and rhlI-rhlR Quorum-Sensing Systems in Pseudomonas aeruginosa.

Authors:  Alison A Jack; Saira Khan; Lydia C Powell; Manon F Pritchard; Konrad Beck; Hina Sadh; Lucy Sutton; Alessandra Cavaliere; Hannah Florance; Philip D Rye; David W Thomas; Katja E Hill
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 5.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

6.  Stand-alone ClpG disaggregase confers superior heat tolerance to bacteria.

Authors:  Changhan Lee; Kamila B Franke; Shady Mansour Kamal; Hyunhee Kim; Heinrich Lünsdorf; Jasmin Jäger; Manfred Nimtz; Janja Trček; Lothar Jänsch; Bernd Bukau; Axel Mogk; Ute Römling
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-20       Impact factor: 11.205

7.  A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development.

Authors:  Francois Lebreton; Erik Snesrud; Lindsey Hall; Emma Mills; Madeline Galac; Jason Stam; Ana Ong; Rosslyn Maybank; Yoon I Kwak; Sheila Johnson; Michael Julius; Melissa Ly; Brett Swierczewski; Paige E Waterman; Mary Hinkle; Anthony Jones; Emil Lesho; Jason W Bennett; Patrick McGann
Journal:  JAC Antimicrob Resist       Date:  2021-12-10

8.  Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.

Authors:  Clair L Preece; Thomas A Wichelhaus; Audrey Perry; Amanda L Jones; Stephen P Cummings; John D Perry; Michael Hogardt
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

9.  Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis.

Authors:  Joseph M Collaco; Karen S Raraigh; Lawrence J Appel; Garry R Cutting
Journal:  J Cyst Fibros       Date:  2016-06-11       Impact factor: 5.482

10.  The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential.

Authors:  Michael M Maiden; Mitchell P Zachos; Christopher M Waters
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.